Cargando…
Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease with a median survival of 2–5 years. An early diagnosis is essential for providing ALS patients the finest management possible. Studies from different countries report a similar median diagnostic delay...
Autores principales: | Falcão de Campos, Catarina, Gromicho, Marta, Uysal, Hilmi, Grosskreutz, Julian, Kuzma-Kozakiewicz, Magdalena, Oliveira Santos, Miguel, Pinto, Susana, Petri, Susanne, Swash, Michael, de Carvalho, Mamede |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886675/ https://www.ncbi.nlm.nih.gov/pubmed/36733448 http://dx.doi.org/10.3389/fneur.2022.1064619 |
Ejemplares similares
-
Delayed Diagnosis and Diagnostic Pathway of ALS Patients in Portugal: Where Can We Improve?
por: Falcão de Campos, Catarina, et al.
Publicado: (2021) -
Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study
por: Hertel, Nora, et al.
Publicado: (2022) -
Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis
por: Barć, Krzysztof, et al.
Publicado: (2020) -
Spreading in ALS: The relative impact of upper and lower motor neuron involvement
por: Gromicho, Marta, et al.
Publicado: (2020) -
Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)